In heart failure, the heart can no longer supply the body with enough blood. The condition often develops over many years, ...

Now, following up on that success, a large Chinese collaboration has followed up with a description of an improved gene ...

Colossal Biosciences is establishing standards for how biotechnology can responsibly support biodiversity conservation in an ...

When CRISPR cuts a gene flanked by short, repeating DNA sequences, the cell’s repair machinery gets confused. It simply zips ...

Innovation often pays off, and this biotech could cement its innovative capabilities in the next few years.

CRISPR Therapeutics (Nasdaq: CRSP) today announced that members of its senior management team will present at the 25th Annual ...

We will know even more about the company's prospects in a year as it releases clinical data for various pipeline candidates.

CRISPR Therapeutics AG (CRSP) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near ...

CRISPR Cas9 gene therapy explained with DNA scissors, hereditary diseases treatment, and designer babies ethical dilemmas ...

In back-to-back studies published in Nature, researchers from Purdue University and Columbia University report a naturally ...

One stock that's been on my watch list for a while is CRISPR Therapeutics (NASDAQ: CRSP). The company has an intriguing ...